MDTD Stock Overview
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Medtronic plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$31.00 |
| 52 Week High | US$0 |
| 52 Week Low | US$0 |
| Beta | 0.72 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 0% |
Recent News & Updates
Recent updates
Shareholder Returns
| MDTD | AR Medical Equipment | AR Market | |
|---|---|---|---|
| 7D | 0% | 0% | 0% |
| 1Y | n/a | 0% | 0% |
Return vs Industry: Insufficient data to determine how MDTD performed against the AR Medical Equipment industry.
Return vs Market: Insufficient data to determine how MDTD performed against the AR Market.
Price Volatility
| MDTD volatility | |
|---|---|
| MDTD Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 0% |
| Market Average Movement | 0% |
| 10% most volatile stocks in AR Market | 0% |
| 10% least volatile stocks in AR Market | 0% |
Stable Share Price: MDTD has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine MDTD's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1949 | 95,000 | Geoff Martha | www.medtronic.com |
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products.
Medtronic plc Fundamentals Summary
| MDTD fundamental statistics | |
|---|---|
| Market cap | US$115.93b |
| Earnings (TTM) | US$3.76b |
| Revenue (TTM) | US$31.23b |
31.2x
P/E Ratio3.8x
P/S RatioIs MDTD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MDTD income statement (TTM) | |
|---|---|
| Revenue | US$31.23b |
| Cost of Revenue | US$10.62b |
| Gross Profit | US$20.61b |
| Other Expenses | US$16.85b |
| Earnings | US$3.76b |
Last Reported Earnings
Apr 28, 2023
Next Earnings Date
Aug 22, 2023
| Earnings per share (EPS) | 2.82 |
| Gross Margin | 65.98% |
| Net Profit Margin | 12.03% |
| Debt/Equity Ratio | 47.0% |
How did MDTD perform over the long term?
See historical performance and comparison